In parallel, but also in apparent contradiction of the well-documented cardio and vascular protective role of TRAIL [1, 3–9], DXA-derived fat indices rather than the respective anthropometric measures are able to predict the risk of metabolic diseases, in primis type II diabetes, and CVD [23–27]. The gene discussed is TNFSF10; the disease is metabolic disease.